SCHEMBL14315445

SCHEMBL14315445

Cc1nc(-c2cc(C(=O)Nc3ccc(C(N)=O)cc3)n(C)c2)cs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 14/20 0.56
▸ RAB9A P51151 14/20 0.56
▸ KDM4E B2RXH2 4/20 0.56
▸ MAPT P10636 4/20 0.56
▸ ALDH1A1 P00352 4/20 0.56
▸ MEN1 O00255 6/20 0.54
▸ KMT2A Q03164 6/20 0.54
▸ MAPK1 P28482 2/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ NFKB1 P19838 3/20 0.53
▸ NFKB2 Q00653 3/20 0.53
▸ RELA Q04206 3/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.49
▸ TP53 P04637 2/20 0.49
▸ STAT1 P42224 2/20 0.48
▸ PKM P14618 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16403925 0.90 RAB9A (0.57) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL14315443 0.89 RAB9A (0.63) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL14325854 0.89 NPC1 (0.53) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL14315442 0.88 NPC1 (0.53) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL16404062 0.88 NPC1 (0.54) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL14317616 0.87 NPC1 (0.52) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL16403950 0.87 RAB9A (0.52) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL14315441 0.87 NPC1 (0.54) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL16403945 0.87 NFKB1 (0.60) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL16403941 0.85 NPC1 (0.50) NPC1RAB9AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937065-B2 Compositions and methods for modulating a kinase CLEVEXEL PHARMA (FR) 2015-01-20 — — US disclosed
US-8937065-B2 Compositions and methods for modulating a kinase CLEVEXEL PHARMA (FR) 2015-01-20 — — US disclosed
WO-2012172438-A9 COMPOSITIONS AND METHODS FOR MODULATING A KINASE DYNAMIX PHARMACEUTICALS LTD. (IL) 2013-02-07 — — WO disclosed
WO-2012172438-A2 COMPOSITIONS AND METHODS FOR MODULATING A KINASE DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-12-20 — — WO disclosed
Send feedback